Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Certara
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
September 19, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Participate in Upcoming Investor Conferences
August 29, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Simcyp™ Group Awarded Two New Grants from US FDA
August 29, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Reports Second Quarter 2023 Financial Results
August 09, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
July 13, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Participate in the Jefferies Global Healthcare Conference
June 02, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Reports First Quarter 2023 Financial Results
May 08, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
April 27, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference
April 10, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
A.I. Coming to Certara’s D360 Scientific Informatics Software
March 09, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
March 07, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
March 01, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Announces Transition Plan for Chief Financial Officer
March 01, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Participate in the Barclays Global Healthcare Conference
February 27, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
February 01, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
January 04, 2023
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
December 08, 2022
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Certara
Via
GlobeNewswire
Tickers
CERT
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
November 07, 2022
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Participate in Upcoming Investor Conferences
November 02, 2022
From
Certara
Via
GlobeNewswire
Tickers
CERT
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
October 19, 2022
From
Certara
Via
GlobeNewswire
Tickers
CERT
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
October 13, 2022
From
Certara
Via
GlobeNewswire
Tickers
CERT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.